GIPL — Global Innovative Platforms Inc.

OTC · Health Care · Health Care Equipment & Supplies · CIK 1837774 ·
Last close
$0.50
Market Cap
52W High
$0.52
52W Low
$0.50
ADV30
37
Next earnings
Global Innovative Platforms Inc. engages in the business of testing breath to detect and assist in the treatment of disease. The company develops Heartworm breath test, which includes breath collection device, to collect shallow breath samples. It also operates VOCAM Plus and FROG platform for gas chromatography, as well as operates A.I. software to provide breath and air analysis. The company was formerly known as Canning Str Corp. and changed its name to Global Innovative Platforms Inc. in September 2021. Global Innovative Platforms Inc. was incorporated in 2020 and is based in Sanford, Florida.
No quarterly fundamentals indexed for this ticker.

Yahoo Snapshot (yfinance, live)

Total Revenue
$136,500
EBITDA
Free Cash Flow
$-482,499
Enterprise Value
$24,224,350
Total Cash
$327,270
Total Debt
$0
Shares Out
0
Trailing EPS
$-208.48
Book Value
$0.00
ROE
-171.8%
ROA
-106.6%
Div Yield

Peers — same industry

TickerNameMarket CapLastDaily %
ISRG INTUITIVE SURGICAL INC $154.64B $436.64
SYK STRYKER CORP $119.99B $313.00
MDT Medtronic plc $99.63B $77.60
BSX BOSTON SCIENTIFIC CORP $85.67B $57.64
MMM 3M CO $80.34B $154.03

News headlines (Yahoo Finance, 1h cache)

Global Innovative Platforms Announces Completion of First Phase of Breath Test Study for Early Heartworm Detection
2025-10-07 14:30 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.